ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Mitochondrial dysfunction is a hallmark of β-amyloid (Aβ)–induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that Aβ-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Aβ to mitochondrial toxicity. Aβ interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of Aβ-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-Aβ interaction and suppresses Aβ-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an Aβ-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-Aβ interaction may be a therapeutic target in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, Aβ interacts specifically with mitochondrial Aβ-binding alcohol dehydrogenase (ABAD), impeding the binding of NAD to ABAD and inducing ROS production.287,288”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [287]
In the citing paper
“A number of studies have associated intraneuronal Ab buildup with hyperphosphorylation of tau protein, 8 disturbed protein trafficking and sorting, 9 reduced expression of synaptic proteins, 10 and mitochondrial dysfunction.11,12”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [11]
In the citing paper
“Aβ, and its precursor APP, localize, in part, to mitochondria in which they can cause mitochondrial dysfunction as evidenced by increased production of RS, enzyme inhibition, loss of cytochrome c, and depolarization of Δψm (Casley et al., 2002a; Kim et al., 2002; Anandatheerthavarada et al., 2003; Jang and Surh, 2003; Lustbader et al., 2004; Liang et al., 2009; Takuma et al., 2009).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
In the citing paper
“Aβ is reported to increase RS in neurons via multiple mechanisms, including direct Aβ-induced RS production, elevated NADPH oxidase activity, interaction with mitochondria-associated Aβ alcohol dehydrogenase, inhibition of cytochrome oxidase (respiratory complex IV), and by causing leakage of electrons from the mitochondrial electron transport chain (Hensley et al., 1994; Canevari et al., 1999; L”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
In the citing paper
“Intracellular Aβ may then enter the mitochondria in which it induces additional RS and magnifies the metabolic deficit”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M. W., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 999
Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472
TAT-Mediated Protein Transduction into Mammalian Cells
Becker-Hapak, M., McAllister, S. S., & Dowdy, S. F. (2001) · Methods · doi:10.1006/meth.2001.1186 · Cited by 384
Du Yan, S., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., et al. (1997) · Nature · doi:10.1038/39522 · Cited by 379
Self-citationRole of mitochondrial dysfunction in Alzheimer's disease
Castellani, R., Hirai, K., Aliev, G., Drew, K. L., Nunomura, A., Takeda, A., Cash, A. D., Obrenovich, M. E., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10389 · Cited by 364
Mitochondria in Alzheimer's disease
Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126
Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity
Du Yan, S., Shi, Y., Zhu, A., Fu, J., Zhu, H., Zhu, Y., Gibson, L., Stern, E., Collison, K., Al-Mohanna, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2145 · Cited by 120
Self-citationGrill, H. P., Zweier, J. L., Kuppusamy, P., Weisfeldt, M. L., & Flaherty, J. T. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90457-x · Cited by 108
Self-citation
Research works printed but not linked: 2
- M. A. Abreoet al. U.S. Patent and Trademark Office serial number 931186 (2002) vol. 9.
- We thank D. Eliezer and T. McGraw for helpful discussions K. D'Amico and L. Tong for help with data collection at the Advanced Photon Source and D. Landry for help with the surface plasmon resonance experiment. This work was supported by P50AG08702 AG16736 AG17490 and NS42855 and in part by Speaker's Fund for Biomedical Research and NIH 1K07AG00959. H.W. is a Pew Scholar of biomedical sciences and a Rita Allen Scholar. The atomic coordinates have been deposited in the Protein Data Bank (PDB accession code 1SO8).
Cited by
Items 701–800 of 1,002
Intracellular Amyloid β-Protein As a Therapeutic Target for Treating Alzheimers Disease
Ohyagi, Y. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898514 · Cited by 44
Oerum, S., Roovers, M., Rambo, R. P., Kopec, J., Bailey, H., Fitzpatrick, F., Newman, J. A., Newman, W. G., Amberger, A., Zschocke, J., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001286 · Cited by 42
Yin, Z., Geng, X., Zhang, Z., Wang, Y., & Gao, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.746711 · Cited by 40
García‐Villoria, J., Navarro‐Sastre, A., Fons, C., Pérez‐Cerdá, C., Baldellou, A., Fuentes-Castelló, M. Á., González, I., Hernández-González, A., Fernández, C., Campistol, J., et al. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.10.006 · Cited by 40
What is the dominant aβ species in human brain tissue? A review
Gregory, G. C., & Halliday, G. M. (2005) · Neurotoxicity Research · doi:10.1007/bf03033774 · Cited by 49
Lessons from two prevalent amyloidoses—what amylin and Aβ have in common
Götz, J., Lim, Y.-A., & Eckert, A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00038 · Cited by 45
Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie · doi:10.1002/ange.200802808 · Cited by 41
Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
Atlante, A., Amadoro, G., Latina, V., & Valenti, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226742 · Cited by 41
Skawratananond, S., Xiong, D. X., Zhang, C., Tonk, S. S., Pinili, A., Delacruz, B., Pham, P., Smith, S. C., Navab, R., & Reddy, P. H. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102732 · Cited by 42
Chen, Y., Han, S., Huang, X., Ni, J., & He, X. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020163 · Cited by 41
Hroch, L., Benek, O., Guest, P. N., Aitken, L., Soukup, O., Janočková, J., Musil, K., Dohnal, V., Doležal, R., Kuča, K., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.05.087 · Cited by 40
Self-citationDiminished stress resistance and defective adaptive homeostasis in age-related diseases
Lomeli, N., Bota, D. A., & Davies, K. J. A. (2017) · Clinical Science · doi:10.1042/cs20160982 · Cited by 41
Defining the ATPome reveals cross-optimization of metabolic pathways
Bennett, N. K., Nguyen, M. K., Darch, M. A., Nakaoka, H. J., Cousineau, D., ten Hoeve, J., Graeber, T. G., Schuelke, M., Maltepe, E., Kampmann, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18084-6 · Cited by 44
Zhang, X., Wang, L., Li, B., Shi, J., Xu, J. F., & Yuan, M. (2023) · Pharmaceuticals · doi:10.3390/ph16020277 · Cited by 44
Casasnovas, R., Ortega‐Castro, J., Donoso, J., Frau, J., & Muñoz, F. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp50840d · Cited by 44
An update on the toxicity of Aβ in Alzheimer’s disease
Götz, J., Ittner, L. M., Schönrock, N., & Cappai, R. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3016 · Cited by 50
Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform
Kolaj, I., Imindu Liyanage, S., & Weaver, D. F. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.001 · Cited by 39
Navigating the intersection: Diabetes and Alzheimer's intertwined relationship
Kale, M. B., Bhondge, H. M., Wankhede, N. L., Shende, P. V., Thanekar, R., Aglawe, M. M., Rahangdale, S. R., Taksande, B. G., Pandit, S. B., Upaganlawar, A. B., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102415 · Cited by 39
Investigating Interventions in Alzheimer's Disease with Computer Simulation Models
Proctor, C. J., Boche, D., Gray, D. A., & Nicoll, J. A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073631 · Cited by 44
Takasaki, S. (2009) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(08)60132-0 · Cited by 38
Derungs, R., Camici, G. G., Spescha, R. D., Welt, T., Tackenberg, C., Späni, C. B., Wirth, F., Grimm, A., Eckert, A., Nitsch, R. M., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.112 · Cited by 43
Virtual screening applications in short-chain dehydrogenase/reductase research
Beck, K. R., Kaserer, T., Schuster, D., & Odermatt, A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.008 · Cited by 40
Ntsapi, C., Lumkwana, D., Swart, C., du Toit, A., & Loos, B. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.07.002 · Cited by 43
Staging anti-inflammatory therapy in Alzheimer’s disease
Lichtenstein, M. P. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00142 · Cited by 39
Fišar, Z., Jirák, R., Zvěřová, M., Setnička, V., Habartová, L., Hroudová, J., Vaníčková, Z., & Raboch, J. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.04.003 · Cited by 39
Song, J. M., DiBattista, A. M., Sung, Y. M., Ahn, J. M., Turner, R. S., Yang, J., Pak, D. T. S., Lee, H., & Hoe, H.-S. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.023 · Cited by 41
Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 45
Mind the Gap: Mitochondria and the Endoplasmic Reticulum in Neurodegenerative Diseases
Leal, N. S., & Martins, L. M. (2021) · Biomedicines · doi:10.3390/biomedicines9020227 · Cited by 42
Nascimento‐dos‐Santos, G., de‐Souza‐Ferreira, E., Linden, R., Galina, A., & Petrs‐Silva, H. (2021) · Cells · doi:10.3390/cells10071827 · Cited by 38
Role of PITRM1 in Mitochondrial Dysfunction and Neurodegeneration
Brunetti, D., Catania, A., Viscomi, C. F., Deleidi, M., Bindoff, L. A., Ghezzi, D., & Zeviani, M. (2021) · Biomedicines · doi:10.3390/biomedicines9070833 · Cited by 42
Interactions between amyloid, amyloid precursor protein, and mitochondria
Wilkins, H. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220518 · Cited by 37
Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer’s disease
Gu, X., Huang, H., & Jiang, Z.-F. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1270-2 · Cited by 42
Treatments for Alzheimer Disease
Potyk, D. K. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000166671.86815.c1 · Cited by 45
Wu, Z., Zhu, Y., Cao, X., Sun, S., & Zhao, B. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8675-z · Cited by 41
Lu, L., Guo, L., Gauba, E., Tian, J., Wang, L., Tandon, N., Shankar, M., Beck, S. J., Du, Y., & Du, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144068 · Cited by 38
Mitochondrial PITRM1 peptidase loss-of-function in childhood cerebellar atrophy
Langer, Y., Aran, A. A., Gülsüner, S., Libdeh, B. Y. A., Renbaum, P., Brunetti, D., Teixeira, P.-F., Walsh, T., Zeligson, S., Ruotolo, R., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105330 · Cited by 38
Defective Autophagy and Mitophagy in Alzheimer’s Disease: Mechanisms and Translational Implications
Chen, J., He, H., Ye, Q., Feng, F., Wang, W., Gu, Y., Han, R., & Xie, C. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02487-7 · Cited by 37
Wilkins, H., Troutwine, B., Menta, B. W., Manley, S., Strope, T., Lysaker, C., & Swerdlow, R. H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215280 · Cited by 41
A Cell Model for the Initial Phase of Sporadic Alzheimer's Disease
Stockburger, C., Gold, V. A. M., Pallas, T., Kolesova, N., Miano, D., Leuner, K., & Müller, W. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140381 · Cited by 41
Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations
Keil, U., Hauptmann, S., Bonert, A., Scherping, I., Eckert, A., & Müller, W. E. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9206 · Cited by 36
Schuh, R. A., Jackson, K. C., Schlappal, A. E., Spangenburg, E. E., Ward, C. W., Park, J. H., Dugger, N. V., Shi, G., & Fishman, P. S. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-24 · Cited by 38
Bellizzi, M. J., Lu, S., & Gelbard, H. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-005-9006-y · Cited by 38
Bioenergetics and metabolism: a bench to bedside perspective
Swerdlow, R. H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13509 · Cited by 35
Yang, Z., Kang, D. H., Lee, H., Shin, J. W., Yan, W., Rathore, B., Kim, H. R., Kim, S. J., Singh, H., Liu, L., et al. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00128 · Cited by 35
Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2018) · BioMed Research International · doi:10.1155/2018/1483791 · Cited by 39
Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
Miziak, B., Błaszczyk, B., & Czuczwar, S. J. (2021) · Pharmaceuticals · doi:10.3390/ph14050458 · Cited by 37
Auto-inhibitory Mechanism of the Human Mitochondrial RNase P Protein Complex
Li, F., Liu, X., Zhou, W., Yang, X., & Shen, Y. (2015) · Scientific Reports · doi:10.1038/srep09878 · Cited by 38
Vangavaragu, J. R., Valasani, K. R., Gan, X., & Yan, S. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.046 · Cited by 37
Self-citationJi, X., Chi, T., Xu, Q., He, X., Xiao-yu, Z., Zhang, R., & Zou, L. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/969342 · Cited by 35
Schaefer, P. M., von Einem, B., Walther, P., Calzia, E., & von Arnim, C. A. F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0168157 · Cited by 34
Current and Emerging Pharmacological Targets for the Treatment of Alzheimer’s Disease
Morsy, A., & Trippier, P. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190744 · Cited by 38
Park, S.-S., Park, H.-S., Kim, C., Baek, S., Park, S., Anderson, C., Kim, M.-K., Park, I.-R., & Kim, T.-W. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00751.2021 · Cited by 38
Boosting mitochondrial health to counteract neurodegeneration
Burtscher, J., Romani, M., Bernardo, G., Popa, T., Ziviani, E., Hummel, F. C., Sorrentino, V., & Millet, G. P. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102289 · Cited by 37
The Mitochondrial Secret(ase) of Alzheimer's Disease
Young, K. J., & Bennett, J. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100360 · Cited by 36
de Tullio, M. B., Morelli, L., & Castaño, E. M. (2008) · Prion · doi:10.4161/pri.2.2.6710 · Cited by 44
New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders
M. Wilkins, H., & K. Morris, J. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230144517 · Cited by 35
Mitochondrial β-amyloid in Alzheimer's disease
Borger, E., Aitken, L., Muirhead, K. E. A., Allen, Z., Ainge, J. A., Conway, S. J., & Gunn, F. J. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390868 · Cited by 39
Self-citationMatsumoto, K., Akao, Y., Yi, H. L., Shamoto‐Nagai, M., Maruyama, W., & Naoi, M. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0318-0 · Cited by 35
Lu, J., Li, Y., Mollinari, C., Garaci, E., Merlo, D., & Pei, G. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191023104036 · Cited by 36
Nepovimová, E., Svobodová, L., Doležal, R., Hepnarová, V., Junova, L., Jun, D., Korábečný, J., Kucera, T., Gažová, Z., Motykova, K., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104596 · Cited by 35
Disturb mitochondrial associated proteostasis: Neurodegeneration and imperfect ageing
Jagtap, Y. A., Kumar, P., Kinger, S., Dubey, A. R., Choudhary, A., Gutti, R. K., Singh, S., Jha, H. C., Poluri, K. M., & Mishra, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1146564 · Cited by 36
Epis, R., Marcello, E. E., Gardoni, F., Longhi, A., Calvani, M., Iannuccelli, M., Cattabeni, F., Canonico, P. L., & Luca, M. D. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.09.001 · Cited by 34
Oxidative Stress and Alzheimer’s Disease
Singh, S. K., Castellani, R. J., & Perry, G. L. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_10 · Cited by 35
Effect of Gender on Mitochondrial Toxicity of Alzheimer's A β Peptide
Viña, J., Lloret, A., Vallés, S. L., Borrás, C., Badía, M.-C., Pallardó, F. V., Sastre, J., & Alonso, M.-D. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1773 · Cited by 37
Wang, D.-S., Dickson, D. W., & Malter, J. S. (2011) · Figshare · doi:10.6084/m9.figshare.10249 · Cited by 32
Mitochondrial transformations in the aging human placenta
Bartho, L. A., Fisher, J. J., Cuffe, J. S. M., & Perkins, A. V. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00354.2020 · Cited by 32
Zhang, S., Liu, F., Li, J., Jing, C., Lü, J., Chen, X., Wang, D., Cao, D., Zhao, D., & Sun, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115442 · Cited by 33
Self-citationAtlante, A., & Valenti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115951 · Cited by 35
Alzheimer disease as a vascular disorder: Where do mitochondria fit?
Correia, S. C., Santos, R. X., Cardoso, S., Carvalho, C., Candeias, E., Duarte, A. I., Plácido, A. I., Santos, M. S., & Moreira, P. I. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.006 · Cited by 41
Pahnke, J., Fröhlich, C., Krohn, M., Schumacher, T., & Paarmann, K. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.007 · Cited by 38
Sen, A., Karasik, A., Shanmuganathan, A., Mirkovic, E., Koutmos, M., & Cox, R. T. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw338 · Cited by 37
Tumor suppressor KIF1Bβ regulates mitochondrial apoptosis in collaboration with YME1L1
Ando, K., Yokochi, T., Mukai, A., Gao, W., Li, Y., Kramer, S., Ozaki, T., Maehara, Y., & Nakagawara, A. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.22997 · Cited by 33
Li, Z.-H., 650223,中国, 中. 昆., He, X., Li, H., He, R., Hu, X., 650204,中国, 中. 昆., 671000,中国, 大. 大., 200031,中国, 中., 650223,中国, 中. 昆., et al. (2020) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.088 · Cited by 35
Mitophagy impairment in neurodegenerative diseases: Pathogenesis and therapeutic interventions
Mani, S., Swargiary, G., & Chadha, R. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.01.001 · Cited by 33
Amyloids: The History of Toxicity and Functionality
Yakupova, E. I., Bobyleva, L. G., Shumeyko, S. A., Vikhlyantsev, I. M., & Bobylev, A. G. (2021) · Biology · doi:10.3390/biology10050394 · Cited by 39
Characterization of Mitochondrial Dysfunction in the 7PA2 Cell Model of Alzheimer's Disease
Krako, N., Magnifico, M. C., Arese, M., Meli, G., Forte, E., Lecci, A., Manca, A., Giuffrè, A., Mastronicola, D., Sarti, P., et al. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130728 · Cited by 33
Takasaki, S. (2008) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2008.03.014 · Cited by 32
Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer’s Disease
He, X., Isaacs, C. E., & Yang, S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170974 · Cited by 33
Bassett, S. S., Avramopoulos, D., Perry, R. T., Wiener, H. W., Watson, B., Go, R. C. P., & Fallin, M. D. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30350 · Cited by 35
Zhou, F., Lian, W., Yuan, X., Wang, Z., Xia, C., Yu, Y., Wang, W., Tong, Z., Cheng, Y., Xu, J., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01695-w · Cited by 36
Yan, X., Xiong, K., Luo, X., Struble, R. G., & Clough, R. W. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21239 · Cited by 36
Xiao, X., Chen, Q., Zhu, X., & Wang, Y. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.05.016 · Cited by 33
The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease
Kim, D., & Mook‐Jung, I. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.12.282 · Cited by 32
Is Amyloid Binding Alcohol Dehydrogenase a Drug Target for Treating Alzheimer’s Disease?
Borger, E., Aitken, L., Du, H., Zhang, W., Gunn‐Moore, F. J., & Yan, S. S. D. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310010004 · Cited by 36
Self-citationSultana, M. A., Hia, R. A., Akinsiku, O., & Hegde, V. K. (2023) · Biology · doi:10.3390/biology12071019 · Cited by 36
Lee, S., Chu, K., Park, J., Hong, N. H., Im, W., Kang, L., Han, Z., Jung, K., Kim, M., & Kim, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05044.x · Cited by 37
Karasik, A., Shanmuganathan, A., Howard, M. J., Fierke, C. A., & Koutmos, M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.11.025 · Cited by 31
Fleck, D., Phu, L., Verschueren, E., Hinkle, T. B., Reichelt, M., Bhangale, T., Haley, B., Wang, Y., Graham, R., Kirkpatrick, D. S., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0116-19.2019 · Cited by 31
Esposito, L., Gan, L., Yu, G., Essrich, C., & Mucke, L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02816.x · Cited by 31
The Journey of Mitochondrial Protein Import and the Roadmap to Follow
Haastrup, M. O., Vikramdeo, K. S., Singh, S., Singh, A. P., & Dasgupta, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032479 · Cited by 38
Potential Retinal Biomarkers in Alzheimer’s Disease
García-Bermúdez, M. Y., Vohra, R., Freude, K., van Wijngaarden, P., Martin, K. R. G., Thomsen, M. S., Aldana, B. I., & Kolko, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115834 · Cited by 33
Mitochondria in aging and age-associated diseases
Pahal, S., Mainali, N., Balasubramaniam, M., Reis, R. J. S., & Ayyadevara, S. (2025) · Mitochondrion · doi:10.1016/j.mito.2025.102022 · Cited by 34
Interplay of Energetics and ER Stress Exacerbates Alzheimer's Amyloid-β (Aβ) Toxicity in Yeast
Chen, X., Bisschops, M. M. M., Agarwal, N. R., Ji, B., Shanmugavel, K. P., & Petranović, D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00232 · Cited by 36
Self-citationJin, X., Guo, J., Wang, L., Zhong, X., Yao, W., Gao, H., & Liu, M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113401 · Cited by 32
González, L. F., Bevilacqua, L. E., & Naves, R. F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122055 · Cited by 32
Callens, M., Loncke, J., & Bultynck, G. (2022) · Cells · doi:10.3390/cells11121963 · Cited by 32
A new perspective on Alzheimer’s disease: m6A modification
Xia, L., Zhang, F., Li, Y., Mo, Y., Zhang, L., Li, Q., Luo, M., Hou, X., Du, Z., Deng, J., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1166831 · Cited by 34
Dementia, stroke and migraine — Some common pathological mechanisms
Sas, K., Párdutz, Á., Toldi, J., & Vécsei, L. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.001 · Cited by 33
Pająk, B., Kania, E., & Orzechowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1805304 · Cited by 40
Kim, H. J., Park, J. W., Byun, J. H., Poon, W. W., Cotman, C. W., Fowlkes, C. C., & Jeon, N. L. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000026 · Cited by 31
Metadata
- Authors
- Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., Trinchese, F., Liu, S., Gunn-Moore, F., Lue, L.-F., Walker, D. G., Kuppusamy, P., Zewier, Z. L., Arancio, O., Stern, D., Yan, S. S., & Wu, H.
- Affiliations
- Harbin Medical University (CN)
- Center for Reproductive Sciences and Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.
- Corresponding author
- Lustbader, Joyce W.
- Cirilli, Maurizio
- Lin, Chang
- Takuma, Kazuhiro
- Wang, Ning
- Yan, Shirley ShiDu
- Wu, Hao
- ORCID
- Venue
- Science
- Published
- 2004-04-16
- Volume
- 304
- Issue
- 5669
- Pages
- 448-452
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2163757074
- Cited by
- 1,303
- References
- 22
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 43 · 2023: 51 · 2022: 53 · 2021: 64 · 2020: 73 · 2019: 63 · 2018: 61 · 2017: 55 · 2016: 71 · 2015: 42 · 2014: 62 · 2013: 59 · 2012: 76
- FWCI
- 38.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-17490, AG 16736, K07AG000959, P50AG008702, P01AG017490, R01AG016736)
- National Institute of Neurological Disorders and Stroke (NS 42855, R01NS042855)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, alcohol dehydrogenase, mitochondrial toxicity, mitochondrial dysfunction, NAD+ binding, protein-protein interaction, oxidative stress, neuronal apoptosis, free radicals, memory impairment, therapeutic target
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amino Acid Sequence, Animals, Binding Sites, Brain, Brain Chemistry, Carrier Proteins, Cells, Cultured, Cerebral Cortex, Crystallization, Hippocampus, Humans, Learning, Memory, Mice, Transgenic, Mitochondria, Models, Molecular, Molecular Sequence Data, Mutation, NAD, Neurons, Protein Binding, Protein Conformation, 3-Hydroxyacyl CoA Dehydrogenases, Amyloid beta-Peptides, Microscopy, Immunoelectron, Reactive Oxygen Species, Microscopy, Confocal, Mice, DNA Fragmentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.